Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.

Quil-A® General Description


Quil-A® is a Brenntag Biosector (Brenntag Nordic A/S) trademark for:

  • An adjuvant based on an extract from Quillaja saponaria Molina. Originally purified and characterized by professor, Dr. Pharm. K. Dalsgaard.
  • Process adaptation for commercial production was developed by Dr. Dalsgaard and Brenntag Biosector in close collaboration.
  • Characterized in our laboratory by HPLC, HPTLC, haemolytic activity, tested for immunological properties and TAMC.

Quil-A® brand adjuvant is used in a wide variety of veterinary vaccines around the world, as well as being used in immunological research into both human and veterinary applications.

The product is a concentrated and lyophilized crystal-like powder containing maximum 5% residual water.

Quil-A® is available in two product versions: the normal 95% lyophilized product, and a version that contains 5% ascorbic acid (vitamin C) added as an antioxidant.
Other products in the market claim to be an equivalent to our product. However, no products present in the marketplace are generic equivalents of the adjuvant we sell under the trademark Quil-A®. 

Standard packing sizes:

Quil-A® is supplied in high density PE-containers of 1 gram, 5 gram and 100 gram.

Typical batch sizes:

5000 – 6000 gram

Official Specifications and Material Safety Data Sheets for Quil-A® (with or without ascorbic acid) can be quickly emailed upon your request.